Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesFesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/04/09
Ellsworth P – Fesoterodine is one of the newest antimuscarinic agent approved for the management of OAB. It is unique in that it shares the same active metabolite as tolterodine, 5–hydoxymethyltolterodine (5–HMT); however, this conversion is established via ubiquitous esterases and not via the cytochrome P450 system, thus providing a faster and more efficient conversion to 5–HMT. Fesoterodine is available in 2 doses, 4 mg and 8 mg. Clinical trials have established a dose response relationship in efficacy parameters as well as improvements in quality of life. As with all antimuscarinics, dry mouth and constipation are the more common side effects. A combination of medical therapy and behavioral therapy improves the overall outcome in management of OAB. Dose flexibility may help improve efficacy outcomes and patient education on the management of common adverse effects may improve tolerability with these agents.
Related Articles
Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity
BJU International, 11/11/09
Relevance Score: 82%
Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09
Relevance Score: 79%
Prevalence and Severity of Undiagnosed Urinary Incontinence in Women
American Journal of Medicine, 10/27/09
Relevance Score: 71%
Etiology and predictors of urinary incontinence and its effect on quality of life
Geriatrics and Gerontology International, 11/17/09
Relevance Score: 70%
Urinary Incontinence Therapy Area Pipeline Report
Internet Source, 10/30/09
Relevance Score: 70%
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
Men Presenting for Radical Prostatectomy on Preoperative Statin Therapy Have Reduced Serum Prostate Specific Antigen
The Journal of Urology, 12/17/09
Hypercalciuria is Related to Osmolar Excretion in Children With Nocturnal Enuresis
The Journal of Urology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor